RxDoctor Payments Data

Arthur Decillis

Internal Medicine · Madison, CTNPI 1215202056

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,047,438 of the $1,048,251 with a category attached, or 99.9%. Alnylam Pharmaceuticals Inc. accounts for 74.5% of it on its own, with 2 other manufacturers making up the rest. Among internal medicine clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,048,251in general payments, 2019–2025

Across 102 payments — averaging $10,277 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alnylam Pharmaceuticals Inc.$781K
  • Exelixis Inc.$154K
  • Daiichi Sankyo Inc.$113K

What the payments were for

  • Consulting fees$1,047,438100%
  • Travel & lodging$2200%
  • Food & beverage$5930%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Alnylam Pharmaceuticals Inc.43$781,190
Exelixis Inc.32$154,452
Daiichi Sankyo Inc.27$112,609

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,048,251 in reported general payments places this provider in the 95th percentile of 2,067 internal medicine providers in Connecticut.

See all internal medicine providers in Connecticut →

Other internal medicine in Madison

See the full list for Connecticut →

Where these figures come from

Is this you, or does something look wrong? →